FrancisL
Computer
- Aug 29, 2001
- 337
There is an interesting point made in the observer today about the productive capacity of pharmaceutical plants.
Quote
"There is a terrible irony in the fact that the growth in scientific research and technology now means we can engineer a vaccine against a new strain within weeks, and yet it can't actually happen. There are only a handful of factories worldwide capable of manufacturing such a vaccine, and they cannot make more than 300 million doses in a year, compared with the several billion shots we would need."
from
Is this true? The question I want to raise, is whether it would be feasible to divert existing capacity that is currently producing other products, into producing vaccines for Bird Flu (when the strain has evolved and been identified)
Quote
"There is a terrible irony in the fact that the growth in scientific research and technology now means we can engineer a vaccine against a new strain within weeks, and yet it can't actually happen. There are only a handful of factories worldwide capable of manufacturing such a vaccine, and they cannot make more than 300 million doses in a year, compared with the several billion shots we would need."
from
Is this true? The question I want to raise, is whether it would be feasible to divert existing capacity that is currently producing other products, into producing vaccines for Bird Flu (when the strain has evolved and been identified)